Do you want to read an article? Please log in or register.
Cardiovascular manifestations and treatment considerations in covid-19
Further Publications
Related content
RECOMMENDED
Cardiovascular Risk and Diseases
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Task Force for the management of COVID-19 of the European Society of Cardiology .
doi: 10.1093/eurheartj/ehab697
Cardiovascular Risk and Diseases
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic
J Am Coll Cardiol.
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, Brown TS, Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA
doi: 10.1016/j.jacc.2020.03.031.
Further Publications
The Science Underlying COVID-19: Implications for the Cardiovascular System
Circulation.
Liu PP, Blet A, Smyth D, Li H
doi: 10.1161/CIRCULATIONAHA.
Further Publications
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports
Am Heart J.
Prasad A, Panhwar S, Hendel RC, Sheikh O, Mushtaq Z, Dollar F, Vinas A, Alraies C, Almonani A, Nguyen TH, Amione-Guerra J, Foster MT, Sisson C, Anderson A, George JC, Kutkut I, Guareña Casillas JA, Badin A
doi: 10.1016/j.ahj.2020.06.009.
Cardiovascular Risk and Diseases
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
JAMA Cardiol.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z
doi: 10.1001/jamacardio.2020.1017.
Further Publications
COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?
J Am Heart Assoc.
Larson AS, Savastano L, Kadirvel R, Kallmes DF, Hassan AE, Brinjikji W
doi: 10.1161/JAHA.120.016793.
Cardiovascular Risk and Diseases
Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
J Am Heart Assoc.
Gupta AK, Jneid H, Addison D, Ardehali H, Boehme AK, Borgaonkar S, Boulestreau R, Clerkin K, Delarche N, DeVon HA, Grumbach IM, Gutierrez J, Jones DA, Kapil V, Maniero C, Mentias A, Miller PS, May Ng S, Parekh JD, Sanchez RH, Teodor Sawicki K, S J M Te Riele A, Ann Remme C, London B
doi: 10.1161/JAHA.120.017013.
Cardiovascular Risk and Diseases
Approach to Acute Cardiovascular Complications in COVID-19 Infection
Circ Heart Fail.
Ranard LS, Fried JA, Abdalla M, Anstey DE, Givens RC, Kumaraiah D, Kodali SK, Takeda K, Karmpaliotis D, Rabbani LE, Sayer G, Kirtane AJ, Leon MB, Schwartz A, Uriel N, Masoumi A
doi: 10.1161/CIRCHEARTFAILURE.
Cardiovascular Risk and Diseases
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Clin Res Cardiol.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y
doi: 10.1007/s00392-020-01626-9.